Navigation Links
BioBehavioral Diagnostics Company to Present at Biotech Showcase™ 2011
Date:1/5/2011

PLYMOUTH MEETING, Pa., Jan. 5, 2011 /PRNewswire/ -- BioBehavioral Diagnostics Company (BioBDx), a privately held diagnostics company which manufactures and markets the Quotient® ADHD System, a tool that aids in the objective and accurate assessment of attention-deficit hyperactivity disorder (ADHD), announced today that Byron Hewett, executive chairman, has been selected to present at Biotech Showcase 2011 in San Francisco, CA.

Mr. Hewett's presentation will be given at the Parc 55 Wyndham Hotel on Tuesday, January 11, 2011 at 1:45 p.m. PST.  The presentation will also be available via web cast at: http://www.corporate-ir.net/ireye/confLobby.zhtml?ticker=W242090&item_id=3599550.

About the Quotient® ADHD SystemThe Quotient® ADHD System measures motion and analyzes shifts in attention state to give an objective picture of the core symptom areas of ADHD.  Clinicians use the Quotient® ADHD Test at the initial visit to assess severity of the three core symptoms of ADHD; hyperactivity, inattention and impulsivity.  Patients may be re-assessed periodically at follow-up visits to guide treatment plans.  The clinician integrates the Quotient® ADHD Test report with information from other assessment tools and the clinical evaluation to help guide the discussion on the treatment plan. For more information about the Quotient® ADHD System, please visit http://www.biobdx.com/Products/QuotientADHDSystem.aspx.

About BioBehavioral Diagnostics CompanyBioBDx manufactures and markets the Quotient® ADHD System, a tool that aids in the objective and accurate assessment of ADHD symptom areas.  We are dedicated to providing physicians, parents and patients with high-value information to guide personalized strategies and to enhance quality of life for patients with ADHD.  Our vision is to provide accurate tools for the diagnosis and management of neurological and psychiatric conditions, leading to a transformation of behavioral medicine.  Founded in 2006, BioBehavioral Diagnostics is a privately held company.

Contacts:BioBDxByron Hewett

Executive Chairman

(610) 260-1492

Byron_Hewett@BioBDx.com

Media or Investors:Tiberend Strategic Advisors, Inc.

212-827-0020

Tamara Bright

tbright@tiberend.com or

Claire Sojda

csojda@tiberend.com
'/>"/>

SOURCE BioBehavioral Diagnostics Company
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Reportlinker Adds The 2011 Clinical Chemistry And Immunodiagnostics Markets US, Europe, Japan: Product Development Opportunities And Business Expansion Strategies For Instrument And Reagent Suppliers
2. Reportlinker Adds The 2011 Molecular Diagnostics Market: DNA Probes and Biochips New Product Development Opportunities and Business Expansion Strategies for Instrument and Reagent Suppliers
3. Reportlinker Adds The 2011 Cancer Diagnostics Market: US, Europe, Japan Emerging Opportunities and Business Expansion Strategies
4. Reportlinker Adds Molecular Diagnostics Markets
5. Reportlinker Adds Molecular Diagnostics - Technologies, Markets and Companies
6. Exagen Diagnostics Awarded $400,000 in Grants Under the QTDP Program
7. Quest Diagnostics® Care360™ EHR Receives ONC-ATCB 2011/2012 Certification
8. Gen-Probe Acquires GTI Diagnostics for $53 Million in Cash
9. Jack Davis, Diagnostics Industry Executive, Joins the HistoRx Board of Directors
10. Ridge Diagnostics, Inc. Presents Clinical Data on Blood Test for Depression at U.S. Psychiatric and Mental Health Congress
11. The Future of Molecular Diagnostics: Innovative Technologies Driving Market Opportunities in Personalized Medicine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... Calif. , June 23, 2016  Blueprint Bio, ... biological discoveries to the medical community, has closed its ... Matthew Nunez . "We have received ... with the capital we need to meet our current ... essentially provide us the runway to complete validation on ...
(Date:6/23/2016)... 23, 2016 On Wednesday, June 22, ... down 0.22%; the Dow Jones Industrial Average edged 0.27% lower ... 2,085.45, down 0.17%. Stock-Callers.com has initiated coverage on the following ... Therapeutics (NASDAQ: NKTR ), Aralez Pharmaceuticals Inc. (NASDAQ: ... BIND ). Learn more about these stocks by accessing ...
(Date:6/23/2016)... ... June 23, 2016 , ... Regulatory Compliance Associates® ... provides a free webinar on Performing Quality Investigations: Getting to Root ... CT at no charge. , Incomplete investigations are still a major concern to ...
(Date:6/23/2016)...  Amgen (NASDAQ: AMGN ) today announced ... life sciences incubator to accelerate the development of new ... at QB3@953 was created to help high-potential life science ... early stage organizations - access to laboratory infrastructure. ... two "Amgen Golden Ticket" awards, providing each winner with ...
Breaking Biology Technology:
(Date:4/19/2016)... The new GEZE SecuLogic access ... "all-in-one" system solution for all door components. It can ... door interface with integration authorization management system, and thus ... minimal dimensions of the access control and the optimum ... offer considerable freedom of design with regard to the ...
(Date:4/14/2016)... April 14, 2016 BioCatch ... Detection, today announced the appointment of Eyal Goldwerger ... role. Goldwerger,s leadership appointment comes at a ... of the deployment of its platform at several of ... technology, which discerns unique cognitive and physiological factors, is ...
(Date:3/31/2016)...  Genomics firm Nabsys has completed a financial  restructuring ... , M.D., who returned to the company in October ... team, including Chief Technology Officer, John Oliver , ... and Vice President of Software and Informatics, Michael ... Dr. Bready served as CEO of Nabsys from 2005-2014 ...
Breaking Biology News(10 mins):